Prenylated Chalcones as Anticancer Agents Against Castration-Resistant Prostate Cancer
Authors:
- Marcos Morales-ReynaMMMarcos Morales-Reyna
- Elisa Elvira Figueroa-AnguloEFElisa Elvira Figueroa-Angulo
- José Espinoza-HicksJEJosé Espinoza-Hicks
- Alejandro Camacho-DávilaACAlejandro Camacho-Dávila
- César López-CamarilloCésar López-Camarillo
- Laura Isabel Vázquez-CarrilloLVLaura Isabel Vázquez-Carrillo
- Alfonso Salgado-AguayoASAlfonso Salgado-Aguayo
- Ángeles Carlos-ReyesÁCÁngeles Carlos-Reyes
- Violeta Deyanira Álvarez-JiménezVÁVioleta Deyanira Álvarez-Jiménez
- Jonathan Puente-RiveraJonathan Puente-Rivera
- María Elizbeth Alvarez-SánchezMaría Elizbeth Alvarez-Sánchez
Open Access
- 5 June 2025
- journal article
- research article
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 93 (2) , 25
Abstract
Prenylated chalcones have garnered attention as potential anticancer agents due to their ability to modulate multiple cancer-related pathways. In this study, we synthesized and evaluated nine novel prenylated chalcone derivatives for their antiproliferative effects against castration-resistant prostate cancer (CRPC) cell lines, DU145 and PC3. Among these, compounds 6d and 7j demonstrated potent cytotoxic activity, with IC50 values comparable to cisplatin, and exhibited selective toxicity towards cancer cells over non-tumorigenic RWPE-1 cells. Mechanistic investigations revealed that these compounds induce apoptosis via mitochondrial membrane depolarization and increased late apoptotic events. Flow cytometry confirmed activation of both early and late apoptotic pathways. These findings highlight the potential of chalcone derivatives 6d and 7j as promising therapeutic candidates for CRPC treatment and support further development of chalcone-based molecules in precision oncology.Keywords
Funding Information
- UACM
- CCyT-2023-IMP-03
This publication has 69 references indexed in Scilit:
- YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSHMolecular and Cellular Biochemistry, 2023
- Synthesis, characterization and evaluation of prenylated chalcones ethers as promising antileishmanial compoundsMolecular Diversity, 2022
- Targeting Bcl-2 for cancer therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistanceCancer Letters, 2021
- Aggregation‐induced Emission Properties of Triphenylamine Chalcone CompoundsJournal of Fluorescence, 2021
- The plant-derived chalcone Xanthoangelol targets the membrane of Gram-positive bacteriaBioorganic & Medicinal Chemistry, 2019
- Biologically active prenylated flavonoids from the genus Sophora and their structure–activity relationship—A reviewPhytotherapy Research, 2019
- Apoptosis-inducing effects and growth inhibitory of a novel chalcone, in human hepatic cancer cells and lung cancer cellsBiomedicine & Pharmacotherapy, 2018
- Cytotoxicity of trans-chalcone and licochalcone A against breast cancer cells is due to apoptosis induction and cell cycle arrestBiomedicine & Pharmacotherapy, 2017
- Guía de la EAU sobre el cáncer de próstata. Parte II: tratamiento del cáncer de próstata avanzado, recidivante y resistente a la castraciónActas Urológicas Españolas, 2011